Increased hospitalizations among sarcoidosis patients from 1998 to 2008: A population-based cohort study

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Gerke, Alicia K ^a   Yang, Ming ^b   Tang, Fan ^b   Cavanaugh, Joseph E ^b   Polgreen, Philip M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Epidemiology; Hospitalizations; Outcomes; Sarcoidosis; Trends

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAID; RETROSPECTIVE STUDY; SARCOIDOSIS; SEASONAL VARIATION; TIME SERIES ANALYSIS; AGE DISTRIBUTION; AGED; COST OF ILLNESS; ETHNOLOGY; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; SEASON; SEX RATIO; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; COST OF ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MEDICAID; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; SEASONS; SEX DISTRIBUTION; UNITED STATES;

EID: 84860791981     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-19     Document Type: Article

References (28)

1. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008, 29:365-377. 10.1016/j.ccm.2008.03.011, 18539232.
2. Statement on sarcoidosis Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160:736-755. Statement on sarcoidosis.
3. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-1889.
4. Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 2006, 27:453-462. 10.1016/j.ccm.2006.04.002, 16880055.
5. Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest 2004, 126:1431-1438. 10.1378/chest.126.5.1431, 15539709.
6. Foreman MG, Mannino DM, Kamugisha L, Westney GE. Hospitalization for patients with sarcoidosis: 1979-2000. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:124-129.
7. Baughman RP, Lower EE. Novel therapies for sarcoidosis. Semin Respir Crit Care Med 2007, 28:128-133. 10.1055/s-2007-970338, 17330197.
8. Balan A, Hoey ET, Sheerin F, Lakkaraju A, Chowdhury FU. Multi-technique imaging of sarcoidosis. Clin Radiol 2010, 65:750-760. 10.1016/j.crad.2010.03.014, 20696303.
9. Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999, 14:1117-1122. 10.1183/09031936.99.14511179, 10596700.
10. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000, 17:60-66.
11. Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, Drent M. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008, 31:1189-1196. 10.1183/09031936.00051907, 18256069.
12. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W, Sands BE. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:201-208.
13. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Muller-Quernheim J, Schlender-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006, 174:795-802. 10.1164/rccm.200603-402OC, 16840744.
14. Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Sarcoidosis-related Mortality in the U.S. from 1988-2007. Am J Respir Crit Care Med 2011, 183:1524-1530. 10.1164/rccm.201010-1679OC, 3137141, 21330454.
15. Agency for Healthcare Research and Quality Overview of the Nationwide Inpatient Sample (NIS) 2009, Agency for Healthcare Research and Quality., http://www.hcup-us.ahrq.gov/nisoverview.jsp
16. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997, 145:234-241. 10.1093/oxfordjournals.aje.a009096, 9012596.
17. James DG, Neville E, Siltzbach LE. A worldwide review of sarcoidosis. Ann N Y Acad Sci 1976, 278:321-334. 10.1111/j.1749-6632.1976.tb47043.x, 1067017.
18. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986, 123:840-845.
19. Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, Vladeck BC. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996, 335:791-799. 10.1056/NEJM199609123351106, 8703185.
20. Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand CS. Depression in sarcoidosis. Am J Respir Crit Care Med 2001, 163:329-334.
21. Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, Knatterud GL, Yeager H, Rose C, Steimel J. Sarcoidosis: social predictors of severity at presentation. Eur Respir J 2004, 24:601-608. 10.1183/09031936.04.00070503, 15459139.
22. Ligon CB, Judson MA. Impact of systemic corticosteroids on healthcare utilization in pateints with sarcoidosis. Am J Med Sci 2011, 341:196-201. 10.1097/MAJ.0b013e3181fe3eb2, 21446079.
23. Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis 2007, 13:1529-1535. 10.1002/ibd.20250, 17828784.
24. Cannom RR, Kaiser AM, Ault GT, Beart RW, Etzioni DA. Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?. Am Surg 2009, 75:1039-1045.
25. Demirkok SS, Basaranoglu M, Akbilgic O. Seasonal variation of the onset of presentations in stage 1 sarcoidosis. Int J Clin Pract 2006, 60:1443-1450. 10.1111/j.1742-1241.2006.00773.x, 17073840.
26. Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 1998, 12:1197-1199. 10.1183/09031936.98.12051197, 9864021.
27. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006, 61:980-985. 10.1136/thx.2006.062836, 2121155, 16844727.
28. Gillman A, Steinfort C. Sarcoidosis in Australia. Intern Med J 2007, 37:356-359. 10.1111/j.1445-5994.2007.01365.x, 17535377.